[Clinical study of calcium-containing bioactive food additive in postmenopausal osteoporosis].
The purpose of the investigation: to study the biological active supplement (BAS) Calcimax influence on the pain syndrome (PS) dynamics and the psycho-emotional breaches, on the ionized calcium level in the blood plasma of the osteoporosis patients. The Calcimax has been produced by the "Artlife" company (Tomsk, Russia). The calcium hydroxiapatit (200 mg per 1 capsule) It is balanced with the microelements and vitamins. 31 women, who suffer from the osteoporosis disease, at the age of 47 to 64, took place in the prospective randomized investigation. All the patients were subdivided in two groups (16 and 15 patients). The basic group patients, exempt prophylaxis and following the recommendations took two capsules after light supper within 6 months. The comparative analysis of the monthly monitoring of the average number of the PS intensity has shown the trustworthy (p < 0.05) lowering of them. The Calcimax rises the (IC) level in the blood plasma also. Thus the Calcimax may be used as the common preventive remedy.
V N
VN
Khodyrev
M M
MM
Vitilina
G M
GM
Lobanova
D002118:Calcium / Q000097:blood*; D019587:Dietary Supplements; D017886:Durapatite / Q000627:therapeutic use*; D020920:Dyssomnias / Q000150:complications; D005221:Fatigue / Q000150:complications; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000097:blood* / Q000150:complications / Q000178:diet therapy* / Q000523:psychology; D010146:Pain / Q000150:complications; D016896:Treatment Outcome
D017886:Durapatite; D002118:Calcium